SK Biopharmaceuticals Announces 100,000 Patients Globally Have Been Treated with ...

Retrieved on: 2024-03-11 14:48:35

Tags for this article:

Click the tags to see associated articles and topics

SK Biopharmaceuticals Announces 100,000 Patients Globally Have Been Treated with .... View article details on HISWAI: https://www.fox44news.com/business/press-releases/cision/20240311NY56803/sk-biopharmaceuticals-announces-100000-patients-globally-have-been-treated-with-cenobamate-through-sales-of-xcopri-and-ontozry-in-the-u-s-europe-israel-and-canada

Summary

The article discusses SK Biopharmaceuticals' anti-seizure medication, Cenobamate, used in treating epilepsy. It highlights the drug's global reach and regulatory approvals, emphasizing its use in pregnancy care due to potential impacts on birth control efficacy.

Article found on: www.fox44news.com

View Original Article